Jonathan Biller

Insider Reports History

Entity
Individual
Location
C/O Celgene Corporation, 86 Morris Avenue, Summit, NJ
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Biller:

Stock Role Class Num Shares Value Price $ Report Date Ownership
VERTEX PHARMACEUTICALS INC / MA EVP and Chief Legal Officer Common Stock 18.3K $7.66M $418.77 Feb 12, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Chief Financial Officer Restricted stock units 11.5K $285K $24.79 Mar 1, 2022 Direct
AGIOS PHARMACEUTICALS, INC. Chief Financial Officer Stock options (right to buy) 41K Mar 1, 2022 Direct

Insider Reports Filed by Jonathan Biller

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 9, 2024 2 -$1.4M 4 Feb 13, 2024 EVP and Chief Legal Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 6, 2024 2 $0 4 Feb 8, 2024 EVP and Chief Legal Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Sep 29, 2023 2 -$355K 4 Oct 3, 2023 EVP and Chief Legal Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 1, 2023 1 $0 4 Feb 3, 2023 EVP and Chief Legal Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Sep 19, 2022 1 $0 4 Sep 21, 2022 EVP and Chief Legal Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Sep 19, 2022 0 $0 3 Sep 21, 2022 EVP and Chief Legal Officer
AGIO AGIOS PHARMACEUTICALS, INC. Mar 1, 2022 2 $0 4 Mar 3, 2022 Chief Financial Officer
AGIO AGIOS PHARMACEUTICALS, INC. Feb 18, 2022 3 -$78.2K 4 Feb 23, 2022 Chief Financial Officer
AGIO AGIOS PHARMACEUTICALS, INC. Feb 10, 2022 3 -$42.4K 4 Feb 14, 2022 Chief Financial Officer
AGIO AGIOS PHARMACEUTICALS, INC. Dec 3, 2021 3 -$65.4K 4 Dec 7, 2021 Chief Financial Officer